Updated August 15, 2016 This content is archived.
Paresh Dandona, MD, PhD, Distinguished Professor of medicine and chief of the Division of Endocrinology, Diabetes and Metabolism, has found that treating patients who have Type 1 diabetes with insulin, liraglutide and dapagliflozin leads to impressive improvements in blood glucose control and weight loss.
